Acute maculopathy after Visian implantable collamer lens (ICL) implantation

Session Details

Session Title: Posterior Chamber Phakic IOLs

Session Date/Time: Sunday 15/09/2019 | 14:00-16:00

Paper Time: 14:44

Venue: Free Paper Forum: Podium 3

First Author: : Z.Yang CHINA

Co Author(s): :    Y. Luo                             

Abstract Details

Purpose:

To report the incidence, clinical presentation and outcomes of acute maculopathy in highly myopic patients after Visian implantable collamer lenses (ICL) implantation.

Setting:

One of the largest academic teaching hospital in mainland China.

Methods:

This is a retrospective, observational, non-comparative case series. A total of 1546 highly myopic eyes that underwent ICL implantation at the Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China between July 2015 and July 2017 were included in the study. All patients who had maculopathy within one month after ICL implantation were included and followed up for at least 6 months. The incidence of acute maculopathy and subsequent treatments were reviewed. The best-corrected visual acuity (BCVA), refractive errors, axial lengths, time between refractive surgery and maculopathy detection and outcomes were analyzed.

Results:

The overall incidence of acute maculopathy was 0.3 % (five eyes of four patients). Three eyes of three patients developed tractional maculopathy (retinoschisis) within 3 days after ICL implantation, and one patient developed bilateral macular hemorrhage 7 to 10 days after ICL implantation, respectively. Mean spherical equivalent (SE) before PIOL implantation was −11.8 diopters (D) (range, −10.0D to −15.5D). All eyes with tractional maculopathy resolved spontaneously. Macular hemorrhage could be absorbed during follow-up. All the eyes had final BCVA similar to the BCVA before the onset of maculopathy.

Conclusions:

The incidence of acute maculopathy after ICL implantation was low. Most of maculopathy were due to vitreo-retinal traction and could be recovered without intervention. The fundus should be evaluated carefully before the operation and risk of acute maculopathy should be informed for patients with extreme myopia.

Financial Disclosure:

None